MedTrace Logo

International Liver Surgery Outcomes Study

NCT03768141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2020-11-20

No results posted yet for this study

Summary

This study was to designed to measure the true worldwide practice of liver surgery and associated outcomes by recruiting multiple international centres, committing to consecutive patient registration per surgeon and undergo rigorous data validation. It is hoped that these data will provide a more appropriate guide to inform surgeons and patients to assess which level of complexity should be routinely offered for high tumour burden and anatomically difficult scenarios.

Conditions

Interventions

PROCEDURE

Liver surgery

All indications (including benign and living donor resections), all co-morbidities, open, laparoscopic or robotic, single wedge resections to extended liver resections, single or two-stage hepatectomies, procedures with liver volume enhancement such as portal vein embolization (PVE), portal vein ligation (PVL), "Associating Liver Partition and Portal vein Ligation for Staged hepatectomy" (ALPPS), resections involving cold perfusion (ex-situ and ante-situ)

Sponsors & Collaborators

  • Hospital Miguel Servet

    collaborator OTHER

  • Royal Free Hospital NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Massimo Malagò, MD, PhD · Royal Free Hospital, London, UK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03768141 on ClinicalTrials.gov